1 – 10 of 31
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Exendin-4 treatment improves LPS-induced depressive-like behavior without affecting pro-inflammatory cytokines
(
- Contribution to journal › Article
- 2012
-
Mark
Neuregulin-1 receptor tyrosine kinase ErbB4 is upregulated in midbrain dopaminergic neurons in Parkinson disease
(
- Contribution to journal › Article
- 2011
-
Mark
Systemic administration of Neuregulin-1ß(1) protects dopaminergic neurons in a mouse model of Parkinson's disease.
(
- Contribution to journal › Article
-
Mark
Signs of Degeneration in 12-22-Year Old Grafts of Mesencephalic Dopamine Neurons in Patients with Parkinson's Disease
(
- Contribution to journal › Article
- 2008
-
Mark
From bench to bed: the potential of stem cells for the treatment of Parkinson's disease
(
- Contribution to journal › Scientific review
- 2007
-
Mark
Midbrain expression of Delta-like 1 homologue is regulated by GDNF and is associated with dopaminergic differentiation.
(
- Contribution to journal › Article
- 2002
-
Mark
Evidence for Dysfunction of the Nigrostriatal Pathway in the R6/1 Line of Transgenic Huntington's Disease Mice.
(
- Contribution to journal › Article
-
Mark
Comparison between survival of lazaroid-treated embryonic nigral neurons in cell suspensions, cultures and transplants.
(
- Contribution to journal › Article
- 2001
-
Mark
The neurobiology of cell transplantation in Parkinson's disease
(
- Contribution to journal › Article
- 2000
-
Mark
FK506 and cyclosporin A enhance the survival of cultured and grafted rat embryonic dopamine neurons
(
- Contribution to journal › Article